Tempus AI (TEM)
67.76
0.00 (0.00%)
Upcoming Events
Latest Headlines
Form EFFECT Tempus AI, Inc.
October 22, 2026 6:03 AM - SEC Filing
Form 424B3 Tempus AI, Inc.
October 21, 2026 4:21 PM - SEC Filing
Form S-4/A Tempus AI, Inc.
October 20, 2026 4:09 PM - SEC Filing
Tempus Presents Data Demonstrating AI-Enabled Pre-Screening Can Help Identify Patients for Biomarker Testing in NSCLC
October 19, 2026 3:03 PM - BizWire
Tempus AI study shows AI pre-screening potential for lung cancer testing
October 19, 2026 8:33 AM - StreetInsider
Tempus Presents Data Demonstrating AI-Enabled Pre-Screening Can Help Identify Patients for Biomarker Testing in NSCLC
October 19, 2026 8:30 AM - BizWire
Tempus AI (TEM) Mentioned Cautiously at Spruce Point
October 16, 2026 10:27 AM - StreetInsider
Tempus to Report Third Quarter 2026 Financial Results on November 2
October 15, 2026 4:01 PM - BizWire
The $1 Trillion AI Healthcare Revolution: A New Era of Medical Innovation Is Taking Shape
October 15, 2026 8:45 AM - StreetInsider
Ambry Genetics launches whole genome sequencing test for rare diseases
October 13, 2026 6:02 AM - StreetInsider
Ambry Genetics Announces GenomeNext™, a Whole Genome Sequencing Test Solution to Improve Diagnosis for Rare Diseases
October 13, 2026 6:00 AM - BizWire
Tempus AI Inc (TEM) PT Raised to $95 at Canaccord
October 12, 2026 6:38 AM - StreetInsider
Tempus AI Inc (TEM) PT Raised to $85 at Baird
October 8, 2026 7:23 AM - StreetInsider
Tempus expands collaboration with Moderna and Merck on cancer therapy
October 7, 2026 8:31 AM - StreetInsider
Tempus Announces Multi-Year Collaboration with Moderna and Merck
October 7, 2026 8:30 AM - BizWire
Form S-4/A Tempus AI, Inc.
October 2, 2026 4:14 PM - SEC Filing
Tempus AI Inc (TEM) PT Raised to $92 at Guggenheim
October 1, 2026 8:48 AM - StreetInsider
Tempus Announces 13 Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2026
October 1, 2026 8:34 AM - BizWire
Form 4 Tempus AI, Inc. For: Sep 25 Filed by: Schoenherr Thomas Edward
September 29, 2026 4:15 PM - SEC Filing
Tempus AI gets FDA clearance for ECG-based heart valve AI tool
September 28, 2026 8:01 AM - StreetInsider
Tempus Receives FDA Clearance for its ECG-MR AI Product Designed to Identify Undiagnosed Mitral Regurgitation
September 28, 2026 8:00 AM - BizWire
Form 144 Tempus AI, Inc. Filed by: Schoenherr Thomas Edward
September 25, 2026 4:20 PM - SEC Filing
Form 4 Tempus AI, Inc. For: Sep 22 Filed by: LEFKOFSKY ERIC P
September 24, 2026 4:15 PM - SEC Filing
Form 144 Tempus AI, Inc. Filed by: LEFKOFSKY ERIC P
September 22, 2026 4:50 PM - SEC Filing
Tempus AI and Recursion extend data deal, add RNA model license
September 21, 2026 9:14 AM - StreetInsider
Tempus and Recursion Extend Existing Data License Agreement and Enter New License Agreement for Recursion’s RNA Foundation Model
September 21, 2026 9:14 AM - BizWire
Goldman Sachs Starts Tempus AI Inc (TEM) at Neutral
September 21, 2026 4:11 AM - StreetInsider
Form 4 Tempus AI, Inc. For: Sep 17 Filed by: LEFKOFSKY ERIC P
September 18, 2026 9:15 PM - SEC Filing
Form 4 Tempus AI, Inc. For: Sep 16 Filed by: Fukushima Ryan
September 18, 2026 9:15 PM - SEC Filing
Form 4 Tempus AI, Inc. For: Sep 17 Filed by: Bartolucci Ryan M
September 18, 2026 9:15 PM - SEC Filing
Form 4 Tempus AI, Inc. For: Sep 17 Filed by: Polovin Andrew
September 18, 2026 9:15 PM - SEC Filing
Form 144 Tempus AI, Inc. Filed by: LEFKOFSKY ERIC P
September 17, 2026 5:06 PM - SEC Filing
Form 144 Tempus AI, Inc. Filed by: Bartolucci Ryan M
September 17, 2026 4:32 PM - SEC Filing
Form 144 Tempus AI, Inc. Filed by: Polovin Andrew
September 17, 2026 4:29 PM - SEC Filing
Form 144 Tempus AI, Inc. Filed by: Fukushima Ryan
September 16, 2026 4:31 PM - SEC Filing
Tempus AI launches whole-genome dataset initiative for AI research
September 11, 2026 8:31 AM - StreetInsider
Tempus Launches Effort to Build the Largest Multimodal Whole-Genome Dataset to Advance AI-Driven Healthcare Innovation
September 11, 2026 8:30 AM - BizWire
Tempus AI Inc (TEM) PT Raised to $66 at H.C. Wainwright
September 11, 2026 6:56 AM - StreetInsider
UBS Assumes Tempus AI Inc (TEM) at Neutral
September 9, 2026 6:09 AM - StreetInsider
Rothschild Redburn Starts Tempus AI Inc (TEM) at Neutral
September 8, 2026 3:27 AM - StreetInsider
Tempus AI Inc (TEM) PT Raised to $70 at Baird
September 3, 2026 7:06 AM - StreetInsider
Cantor Fitzgerald Starts Tempus AI Inc (TEM) at Overweight
September 2, 2026 6:07 AM - StreetInsider
Canaccord Reiterates Buy Rating on Tempus AI Inc (TEM)
September 1, 2026 3:54 AM - StreetInsider
Piper Sandler Upgrades Tempus AI Inc (TEM) to Overweight, 'On A Train Back To Upside, We're Not Jumping the Gun'
September 1, 2026 3:45 AM - StreetInsider
Form 4 Tempus AI, Inc. For: Aug 25 Filed by: LEFKOFSKY ERIC P
August 27, 2026 8:29 PM - SEC Filing
Form 4 Tempus AI, Inc. For: Aug 25 Filed by: LEFKOFSKY ERIC P
August 27, 2026 8:27 PM - SEC Filing
Form 144 Tempus AI, Inc. Filed by: LEFKOFSKY ERIC P
August 25, 2026 4:58 PM - SEC Filing
Form 4 Tempus AI, Inc. For: Aug 21 Filed by: Fukushima Ryan
August 25, 2026 4:15 PM - SEC Filing
Form 4 Tempus AI, Inc. For: Aug 21 Filed by: Schoenherr Thomas Edward
August 25, 2026 4:15 PM - SEC Filing
Tempus AI gets FDA clearance for ECG-based AI pulmonary hypertension tool
August 24, 2026 8:32 AM - StreetInsider
Tempus Receives FDA Clearance for its AI Product Intended to Detect Signs of Pulmonary Hypertension From Standard ECGs
August 24, 2026 8:30 AM - BizWire
Form 144 Tempus AI, Inc. Filed by: Fukushima Ryan
August 21, 2026 4:34 PM - SEC Filing
Form 144 Tempus AI, Inc. Filed by: Schoenherr Thomas Edward
August 21, 2026 4:33 PM - SEC Filing
Form 4 Tempus AI, Inc. For: Aug 18 Filed by: LEFKOFSKY ERIC P
August 20, 2026 9:01 PM - SEC Filing
Form 4 Tempus AI, Inc. For: Aug 18 Filed by: Fukushima Ryan
August 20, 2026 9:01 PM - SEC Filing
Form 4 Tempus AI, Inc. For: Aug 18 Filed by: Schoenherr Thomas Edward
August 20, 2026 9:00 PM - SEC Filing
Form 4 Tempus AI, Inc. For: Aug 18 Filed by: Polovin Andrew
August 20, 2026 9:00 PM - SEC Filing
Form 4 Tempus AI, Inc. For: Aug 18 Filed by: Bartolucci Ryan M
August 20, 2026 9:00 PM - SEC Filing
Form 4 Tempus AI, Inc. For: Aug 18 Filed by: Rogers James William
August 20, 2026 9:00 PM - SEC Filing
Form 144 Tempus AI, Inc. Filed by: LEFKOFSKY ERIC P
August 19, 2026 5:04 PM - SEC Filing
Form 144 Tempus AI, Inc. Filed by: Polovin Andrew
August 19, 2026 5:02 PM - SEC Filing
Form 144 Tempus AI, Inc. Filed by: Fukushima Ryan
August 19, 2026 5:01 PM - SEC Filing
Form 144 Tempus AI, Inc. Filed by: Bartolucci Ryan M
August 19, 2026 5:00 PM - SEC Filing
Form 144 Tempus AI, Inc. Filed by: Rogers James William
August 19, 2026 4:58 PM - SEC Filing
Form 144 Tempus AI, Inc. Filed by: Schoenherr Thomas Edward
August 19, 2026 4:56 PM - SEC Filing
Form 144 Tempus AI, Inc. Filed by: Rogers James William
August 19, 2026 4:39 PM - SEC Filing
Form 144 Tempus AI, Inc. Filed by: Polovin Andrew
August 19, 2026 4:32 PM - SEC Filing
Form 144 Tempus AI, Inc. Filed by: Schoenherr Thomas Edward
August 19, 2026 4:32 PM - SEC Filing
Form 4 Tempus AI, Inc. For: Aug 14 Filed by: West Nadja
August 18, 2026 4:15 PM - SEC Filing
Form 144 Tempus AI, Inc. Filed by: West Nadja
August 14, 2026 4:44 PM - SEC Filing
Form 4 Tempus AI, Inc. For: Aug 12 Filed by: Fukushima Ryan
August 14, 2026 4:34 PM - SEC Filing
Form 4 Tempus AI, Inc. For: Aug 07 Filed by: Fukushima Ryan
August 11, 2026 5:30 PM - SEC Filing
AI Found an Influenza Target That Survives Viral Mutation
August 10, 2026 9:10 AM - StreetInsider
Form 144 Tempus AI, Inc. Filed by: Fukushima Ryan
August 7, 2026 4:37 PM - SEC Filing
CellCarta Adds Tempus to CDx Commercialization Lab Network
August 6, 2026 9:15 AM - PR NewsWire
Form 4 Tempus AI, Inc. For: Aug 03 Filed by: Epstein David R
August 5, 2026 4:31 PM - SEC Filing
Form 4 Tempus AI, Inc. For: Aug 03 Filed by: Fukushima Ryan
August 5, 2026 4:30 PM - SEC Filing
Tempus Study Published in Nature Medicine Demonstrates Best-in-Class Performance of PRISM2 Across Diagnostic and Prognostic Applications
August 4, 2026 8:30 AM - BizWire
Tempus AI Inc (TEM) PT Lowered to $56 at Piper Sandler
August 4, 2026 6:55 AM - StreetInsider
Tempus AI Inc (TEM) PT Lowered to $56 at H.C. Wainwright
August 4, 2026 6:50 AM - StreetInsider
Form 144 Tempus AI, Inc. Filed by: Epstein David R
August 3, 2026 4:49 PM - SEC Filing
Form 144 Tempus AI, Inc. Filed by: Fukushima Ryan
August 3, 2026 4:18 PM - SEC Filing
Tempus AI Inc (TEM) PT Lowered to $70 at BTIG
August 3, 2026 1:49 PM - StreetInsider
Tempus AI Inc (TEM) PT Lowered to $50 at Stifel Amid Hereditary Weakness
August 3, 2026 8:02 AM - StreetInsider
Form 4 Tempus AI, Inc. For: Jul 29 Filed by: Polovin Andrew
July 31, 2026 5:00 PM - SEC Filing
Form 4 Tempus AI, Inc. For: Jul 29 Filed by: Rogers James William
July 31, 2026 4:59 PM - SEC Filing
Tempus AI Inc (TEM) PT Lowered to $59 at Baird
July 31, 2026 7:21 AM - StreetInsider
Form 4 Tempus AI, Inc. For: Jul 28 Filed by: LEFKOFSKY ERIC P
July 30, 2026 9:43 PM - SEC Filing
Tempus AI, Inc (TEM) Tops Q2 EPS by 4c ; Offers Guidance
July 30, 2026 4:28 PM - StreetInsider
Form 10-Q Tempus AI, Inc. For: Jun 30
July 30, 2026 4:04 PM - SEC Filing
Form 8-K Tempus AI, Inc. For: Jul 30
July 30, 2026 4:01 PM - SEC Filing
Tempus Reports Second Quarter 2026 Results
July 30, 2026 4:01 PM - BizWire
Form 144 Tempus AI, Inc. Filed by: LEFKOFSKY ERIC P
July 28, 2026 4:40 PM - SEC Filing
TD Cowen reports short interest changes in life science stocks
July 27, 2026 12:15 PM - StreetInsider
H.C. Wainwright Reiterates Buy Rating on Tempus AI Inc (TEM)
July 24, 2026 7:26 AM - StreetInsider
Full Article List
